Assessing antidepressant activity in rodents: recent developments and future needs

Wong, 2001, Research and treatment approaches to depression, Nat. Rev. Neurosci., 2, 343, 10.1038/35072566

1994

McKinney, 1969, Animal model of depression. I. Review of evidence: implications for research, Arch. Gen. Psychiatry, 21, 240, 10.1001/archpsyc.1969.01740200112015

Geyer, 1995, Animal models of psychiatric disorders, 787

Willner, 1990, Animal models of depression: an overview, Pharmacol. Ther., 45, 425, 10.1016/0163-7258(90)90076-E

Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0

Porsolt, 2000, Animal models of depression: utility for transgenic research, Rev. Neurosci., 11, 53, 10.1515/REVNEURO.2000.11.1.53

Borsini, 1988, Is the forced swimming test a suitable model for revealing antidepressant activity?, Psychopharmacology (Berl.), 94, 147, 10.1007/BF00176837

Lucki, 1997, The forced swimming test as a model for core and component behavioral effects of antidepressant drugs, Behav. Pharmacol., 8, 523, 10.1097/00008877-199711000-00010

Cryan, 2000, Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors, J. Pharmacol. Exp. Ther., 295, 1120

Cryan, 2002, Noradrenergic lesions differentially alter the antidepressant-like effect of reboxetine in a modified forced swim test, Eur. J. Pharmacol., 436, 197, 10.1016/S0014-2999(01)01628-4

Detke, 1997, Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression, Exp. Clin. Psychopharmacol., 5, 107, 10.1037/1064-1297.5.2.107

Molina-Hernandez, 2001, Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim, Psychoneuroendocrinology, 26, 479, 10.1016/S0306-4530(01)00007-5

Reneric, 2001, Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test, Neuropsychopharmacology, 24, 379, 10.1016/S0893-133X(00)00214-1

Espejo, 1999, Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test, Neuroscience, 88, 609, 10.1016/S0306-4522(98)00258-9

Stogner, 2000, Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats, Eur. J. Pharmacol., 387, R9, 10.1016/S0014-2999(99)00800-6

Kelly, 1997, The olfactory bulbectomized rat as a model of depression: an update, Pharmacol. Ther., 74, 299, 10.1016/S0163-7258(97)00004-1

Cryan, 1998, Combining pindolol and paroxetine in an animal model of chronic antidepressant action – can early onset of action be detected?, Eur. J. Pharmacol., 352, 23, 10.1016/S0014-2999(98)00402-6

Stock, 2001, Changes in defensive behaviors following olfactory bulbectomy in male and female rats, Brain Res., 903, 242, 10.1016/S0006-8993(01)02421-0

Primeaux, 1999, Role of aversively motivated behavior in the olfactory bulbectomy syndrome, Physiol. Behav., 67, 41, 10.1016/S0031-9384(99)00027-X

Mar, 2000, Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat, Psychopharmacology (Berl.), 150, 52, 10.1007/s002130000400

Zhou, 1998, Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat, J. Neurosci. Res., 54, 109, 10.1002/(SICI)1097-4547(19981001)54:1<109::AID-JNR11>3.0.CO;2-2

Connor, 1999, Stressor-induced alterations in serotonergic activity in an animal model of depression, NeuroReport, 10, 523, 10.1097/00001756-199902250-00015

Ho, 2000, Striatal glutamate release during novelty exposure-induced hyperactivity in olfactory bulbectomized rats, Neurosci. Lett., 287, 117, 10.1016/S0304-3940(00)01152-6

Bissette, 2001, Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats, Pharmacol. Biochem. Behav., 69, 269, 10.1016/S0091-3057(01)00513-5

Holmes, 1998, Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory/limbic system, Neuroscience, 86, 587, 10.1016/S0306-4522(98)00029-3

Wrynn, 2000, An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression, Brain Res., 879, 193, 10.1016/S0006-8993(00)02619-6

Slotkin, 1999, Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats, J. Pharmacol. Exp. Ther., 289, 334

Weiss, 1998, Animal models of depression and schizophrenia, 88

Gambarana, 2001, Animal models for the study of antidepressant activity, Brain Res. Protocol., 7, 11, 10.1016/S1385-299X(00)00056-8

Reid, 1997, Chronic mild stress and depressive disorder: a useful new model?, Psychopharmacology (Berl.), 134, 365, 10.1007/s002130050471

Vollmayr, 2001, Learned helplessness in the rat: improvements in validity and reliability, Brain Res. Protocol, 8, 1, 10.1016/S1385-299X(01)00067-8

Kokkinidis, 1986, Amphetamine withdrawal: a behavioral evaluation, Life Sci., 38, 1617, 10.1016/0024-3205(86)90501-1

Barr, 1999, Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement, Psychopharmacology (Berl.), 141, 99, 10.1007/s002130050812

Barr, 1999, Effects of withdrawal from an escalating dose schedule of d-amphetamine on sexual behavior in the male rat, Pharmacol. Biochem. Behav., 64, 597, 10.1016/S0091-3057(99)00156-2

Markou, 1991, Postcocaine anhedonia. An animal model of cocaine withdrawal, Neuropsychopharmacology, 4, 17

Kokkinidis, 1980, Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants, Pharmacol. Biochem. Behav., 13, 379, 10.1016/0091-3057(80)90242-7

Kornetsky, 1979, Euphorigenic drugs: effects on the reward pathways of the brain, Fed. Proc., 38, 2473

Moreau, 1992, Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats, Eur. Neuropsychopharmacol., 2, 43, 10.1016/0924-977X(92)90035-7

Harrison, 2001, Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats, Neuropsychopharmacology, 25, 55, 10.1016/S0893-133X(00)00237-2

Barr, 2002, Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats, Psychopharmacology, 159, 196, 10.1007/s002130100906

Crawley, 2000, What's Wrong With My Mouse?

Lucki, 2001, Sensitivity to the effects of pharmacologically selective antidepressants indifferent strains of mice, Psychopharmacology (Berl.), 155, 315, 10.1007/s002130100694

Liu, 2000, Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice, Biol. Psychiatry, 49, 575, 10.1016/S0006-3223(00)01028-3

Lopez-Rubalcava, 2000, Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test, Neuropsychopharmacology, 22, 191, 10.1016/S0893-133X(99)00100-1

Lahmame, 1997, Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?, Eur. J. Pharmacol., 337, 115, 10.1016/S0014-2999(97)01276-4

Vollmayr, 2001, Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness, Mol. Psychiatry, 6, 471, 10.1038/sj.mp.4000907

Vaugeois, 1996, A genetic mouse model of helplessness sensitive to imipramine, Eur. J. Pharmacol., 316, R1, 10.1016/S0014-2999(96)00800-X

Yadid, 2000, Elucidation of the neurobiology of depression: insights from a novel genetic animal model, Prog. Neurobiol., 62, 353, 10.1016/S0301-0082(00)00018-6

Knapp, 2000, Selective breeding of 5-HT1A receptor-mediated responses: application to emotion and receptor action, Pharmacol. Biochem. Behav., 67, 70170, 10.1016/S0091-3057(00)00415-9

Nolan, 2000, A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse, Nat. Genet., 25, 440, 10.1038/78140

Bonaventure, 1999, Humanization of mouse 5-hydroxytryptamine1B receptor gene by homologous recombination: in vitro and in vivo characterization, Mol. Pharmacol., 56, 54, 10.1124/mol.56.1.54

Rupniak, 2001, Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs, Behav. Pharmacol., 12, 497, 10.1097/00008877-200111000-00011

Harro, 2001, The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat, Neuropeptides, 35, 100, 10.1054/npep.2001.0851

Mansbach, 1997, Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist, Eur. J. Pharmacol., 323, 21, 10.1016/S0014-2999(97)00025-3

Healy, 1999, Metyrapone displays antidepressant-like properties in preclinical paradigms, Psychopharmacology (Berl.), 145, 303, 10.1007/s002130051062

Li, 2001, Antidepressant-like actions of an AMPA receptor potentiator (LY392098), Neuropharmacology, 40, 1028, 10.1016/S0028-3908(00)00194-5

Mayorga, 2001, Limitations on the use of the C57BL/6 mouse in the tail suspension test, Psychopharmacology (Berl.), 155, 110, 10.1007/s002130100687

Alonso, 2000, Behavioral despair in mice after prenatal stress, J. Physiol. Biochem., 56, 77, 10.1007/BF03179902

Dugovic, 1999, High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations, J. Neurosci., 19, 8656, 10.1523/JNEUROSCI.19-19-08656.1999

Willner, 1997, Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation, Psychopharmacology (Berl.), 134, 319, 10.1007/s002130050456

Mitchell, 1997, Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635, Behav. Pharmacol., 8, 585, 10.1097/00008877-199711000-00016